Education
About Us
Working with TipRanks
Follow Us
Northwest Biotherapeutics (NWBO)
:NWBO
Dcvax-Direct
Brain Metastases, Breast Cancer Metastatic, Lung Cancer Metastatic
Phase I
Unknown
Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer
Aug 15, 2018
―
Dcvax-Direct
Colorectal Cancer, Pancreatic Cancer, Melanoma, Locally Advanced Tumor, Metastatic Solid Tissue Tumors, Liver Cancer
Phase I/II
Unknown
Safety and Efficacy Study of DCVax-Direct in Solid Tumors
Jun 14, 2013
―
Dendritic Cell Immunotherapy
Glioma, Glioblastoma, Brain Tumor, Gbm, Glioblastoma Multiforme, Grade Iv Astrocytoma, Brain Cancer
Phase III
Unknown
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Sep 17, 2002
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Northwest Biotherapeutics (NWBO) have in its pipeline
NWBO is currently developing the following drugs: Dcvax-Direct, Dcvax-Direct, Dendritic Cell Immunotherapy. These drug candidates are in various stages of clinical development as the company works toward FDA approval.